Skip to main content

and
  1. Article

    Open Access

    Impact of body mass index on pathological response after neoadjuvant chemotherapy: results from the I-SPY 2 trial

    Increased body mass index (BMI) has been associated with poor outcomes in women with breast cancer. We evaluated the association between BMI and pathological complete response (pCR) in the I-SPY 2 trial.

    Haiyun Wang, Douglas Yee, David Potter in Breast Cancer Research and Treatment (2024)

  2. Article

    Patient perspectives on window of opportunity clinical trials in early-stage breast cancer

    Window of opportunity trials (WOT) are increasingly common in oncology research. In WOT participants receive a drug between diagnosis and anti-cancer treatment, usually for the purpose of investigating that dr...

    Divya A. Parikh, Lisa Kody, Susie Brain in Breast Cancer Research and Treatment (2022)

  3. Article

    The WISDOM study: a new approach to screening can and should be tested

    Laura Esserman, Martin Eklund, Laura van’t Veer in Breast Cancer Research and Treatment (2021)